Cargando…

MUC16 Is Overexpressed in Idiopathic Pulmonary Fibrosis and Induces Fibrotic Responses Mediated by Transforming Growth Factor-β1 Canonical Pathway

Several transmembrane mucins have demonstrated that they contribute intracellularly to induce fibrotic processes. The extracellular domain of MUC16 is considered as a biomarker for disease progression and death in IPF patients. However, there is no evidence regarding the signalling capabilities of M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ballester, Beatriz, Milara, Javier, Montero, Paula, Cortijo, Julio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8235375/ https://www.ncbi.nlm.nih.gov/pubmed/34204432 http://dx.doi.org/10.3390/ijms22126502

Ejemplares similares

Pirfenidone anti-fibrotic effects are partially mediated by the inhibition of MUC1 bioactivation
por: Ballester, Beatriz, et al.
Publicado: (2020)

Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets
por: Ballester, Beatriz, et al.
Publicado: (2019)

Mucins as a New Frontier in Pulmonary Fibrosis
por: Ballester, Beatriz, et al.
Publicado: (2019)

MUC1 deficiency mediates corticosteroid resistance in chronic obstructive pulmonary disease
por: Milara, Javier, et al.
Publicado: (2018)

The JAK2 pathway is activated in idiopathic pulmonary fibrosis
por: Milara, Javier, et al.
Publicado: (2018)

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis
por: Estornut, Cristina, et al.
Publicado: (2022)

The role of mucin 1 in respiratory diseases
por: Ballester, Beatriz, et al.
Publicado: (2021)

IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis
por: Milara, Javier, et al.
Publicado: (2022)

The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension
por: Roger, Inés, et al.
Publicado: (2021)

Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms
por: Montero, Paula, et al.
Publicado: (2021)

Anti-Inflammatory and Anti-Fibrotic Profile of Fish Oil Emulsions Used in Parenteral Nutrition-Associated Liver Disease
por: Pastor-Clerigues, Alfonso, et al.
Publicado: (2014)

Influence of dose and exposition time in the effectiveness of N-Acetyl-l-cysteine treatment in A549 human epithelial cells
por: Montero, Paula, et al.
Publicado: (2023)

Evaluation of Delayed-Type Hypersensitivity to Antineoplastic Drugs—An Overview
por: Roger, Inés, et al.
Publicado: (2023)

Increased Expression of Galectin-3 in Skin Fibrosis: Evidence from In Vitro and In Vivo Studies
por: Peiró, Teresa, et al.
Publicado: (2022)

Roflumilast Prevents the Metabolic Effects of Bleomycin-Induced Fibrosis in a Murine Model
por: Milara, Javier, et al.
Publicado: (2015)

The pan-JAK inhibitor LAS194046 reduces neutrophil activation from severe asthma and COPD patients in vitro
por: Milara, Javier, et al.
Publicado: (2022)

Obacunone Photoprotective Effects against Solar-Simulated Radiation–Induced Molecular Modifications in Primary Keratinocytes and Full-Thickness Human Skin
por: Montero, Paula, et al.
Publicado: (2023)

Senescence Alterations in Pulmonary Hypertension
por: Roger, Inés, et al.
Publicado: (2021)

Overexpression of MUC16 predicts favourable prognosis in MUC16-mutant cervical cancer related to immune response
por: Wang, Hao, et al.
Publicado: (2020)

The Possible Pathogenesis of Idiopathic Pulmonary Fibrosis considering MUC5B
por: Zhang, Qinghua, et al.
Publicado: (2019)

Evaluation of Antineoplastic Delayed-Type Hypersensitivity Skin Reactions In Vitro
por: Roger, Inés, et al.
Publicado: (2022)

Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma
por: Bose, Mukulika, et al.
Publicado: (2022)

Antifibrotic therapy for fibrotic lung disease beyond idiopathic pulmonary fibrosis
por: Collins, Bridget F., et al.
Publicado: (2019)

Disease progression in idiopathic pulmonary fibrosis under anti-fibrotic treatment
por: Cilli, Aykut, et al.
Publicado: (2023)

Severity of cough in idiopathic pulmonary fibrosis is associated with MUC5 B genotype
por: Scholand, Mary Beth, et al.
Publicado: (2014)

Paclitaxel-Induced Epidermal Alterations: An In Vitro Preclinical Assessment in Primary Keratinocytes and in a 3D Epidermis Model
por: Montero, Paula, et al.
Publicado: (2022)

Nitric Oxide System and Bronchial Epithelium: More Than a Barrier
por: Bayarri, María Amparo, et al.
Publicado: (2021)

Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States
por: Dempsey, Timothy M., et al.
Publicado: (2022)

Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
por: Astor, Todd L., et al.
Publicado: (2023)

Molecular and Clinical Predictors of Quality of Life in Chronic Rhinosinusitis with Nasal Polyps
por: Brunet, Aina, et al.
Publicado: (2023)

Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist
por: Milara, Javier, et al.
Publicado: (2015)

Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
por: Khor, Yet H., et al.
Publicado: (2020)

Pulmonary vascular volume is associated with DLCO and fibrotic score in idiopathic pulmonary fibrosis: an observational study
por: Wu, Wen-Jui, et al.
Publicado: (2022)

Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism
por: Cocconcelli, Elisabetta, et al.
Publicado: (2022)

Digital quantification of p16-positive foci in fibrotic interstitial lung disease is associated with a phenotype of idiopathic pulmonary fibrosis with reduced survival
por: Keow, Jonathan, et al.
Publicado: (2022)

Paclitaxel Induces Epidermal Molecular Changes and Produces Subclinical Alterations in the Skin of Gynecological Cancer Patients
por: Montero, Paula, et al.
Publicado: (2022)

Muc5b overexpression causes mucociliary dysfunction and enhances lung fibrosis in mice
por: Hancock, Laura A., et al.
Publicado: (2018)

Anti-fibrotic effects of nintedanib in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
por: Hostettler, Katrin E, et al.
Publicado: (2014)

A model of human lung fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis
por: Roach, Katy M., et al.
Publicado: (2018)

Changes in patient-reported outcomes in patients with non-idiopathic pulmonary fibrosis fibrotic interstitial lung disease and progressive pulmonary fibrosis
por: Takei, Reoto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_lo0s7mldtmsggt03b0gr3irm3d